{"text": ["Novartis", "Generics", "Face", "'Challenging", "Quarter,'", "But", "Gene", "Therapy", "Shines"], "created_at": "2021-04-27 20:12:18"}
{"text": ["Eli", "Lil\u00adly", "Aban\u00addons", "IL-23", "Psoriasis", "Program,", "Instead", "Will", "Focus", "On", "Ulcerative", "Colitis,", "Crohn's", "Disease", "Indications"], "created_at": "2021-04-27 18:34:25"}
{"text": ["ANI", "Pharmaceuticals,", "Inc.", "--", "Moody's", "assigns", "first-time", "B2", "CFR", "to", "ANI", "Pharmaceuticals;", "outlook", "stable"], "created_at": "2021-04-27 17:41:06"}
{"text": ["Novartis", "(NVS)", "Q1", "2021", "Earnings", "Call", "Transcript"], "created_at": "2021-04-27 17:30:44"}
{"text": ["Novartis", "(NVS)", "Q1", "Earnings", "&", "Sales", "Miss", "Estimates", "on", "COVID-19", "Woes"], "created_at": "2021-04-27 16:47:04"}
{"text": ["Why", "Novartis", "Missed", "Wall", "Street", "Q1", "Estimates"], "created_at": "2021-04-27 15:53:00"}
{"text": ["Novartis", "Earnings,", "Sales", "Slightly", "Miss", "Q1", "Views"], "created_at": "2021-04-27 14:26:18"}
{"text": ["Novartis", "Earnings,", "Sales", "Slightly", "Miss", "First-Quarter", "Views"], "created_at": "2021-04-27 14:26:18"}
{"text": ["Italy", "judge", "sends", "Bayer,", "Novartis", "to", "trial", "in", "drugs", "fraud", "probe:", "sources"], "created_at": "2021-04-27 11:53:17"}
{"text": ["Italy", "judge", "sends", "Bayer,", "Novartis", "to", "trial", "in", "drugs", "fraud", "probe", "-", "sources"], "created_at": "2021-04-27 11:49:03"}
{"text": ["Novartis", "Q1", "Earnings", "Take", "A", "Hit", "Amid", "COVID-19", "Impact"], "created_at": "2021-04-27 11:45:55"}
{"text": ["Novartis", "key", "growth", "drivers", "and", "launches", "continue", "momentum", "in", "Q1,", "maintaining", "confidence", "in", "growth.", "Group", "guidance", "for", "FY", "2021", "confirmed."], "created_at": "2021-04-27 05:00:00"}
{"text": ["Novartis", "warns", "of", "pandemic", "delay", "in", "cancer", "diagnoses"], "created_at": "2021-04-27 00:00:00"}
